Nonhomologous end joining key factor XLF enhances both 5-florouracil and oxaliplatin resistance in colorectal cancer

Title
Nonhomologous end joining key factor XLF enhances both 5-florouracil and oxaliplatin resistance in colorectal cancer
Authors
Keywords
-
Journal
OncoTargets and Therapy
Volume Volume 12, Issue -, Pages 2095-2104
Publisher
Dove Medical Press Ltd.
Online
2019-03-20
DOI
10.2147/ott.s192923

Ask authors/readers for more resources

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started